Business Wire

ASC24

7.2.2024 10:31:30 CET | Business Wire | Press release

Share
ASC24 Student Supercomputer Challenge: Twenty-five University Teams Worldwide Advance to the Finals

The preliminary results for the 2024 ASC Student Supercomputer Challenge (ASC24) have been announced. Over 300 universities worldwide participated, with twenty-five standout teams advancing to the finals. Among the finalists are renowned institutions such as Huazhong University of Science and Technology, Peking University, the Chinese University of Hong Kong, National Tsing Hua University, Friedrich-Alexander-University Erlangen-Nuremberg, and the National University of Cordoba. They will compete for prestigious awards including the Champion, Silver Prize, Group Competition Award, e Prize, and Highest LINPACK at the finals hosted by Shanghai University from April 9 to 13, 2024.

In response to the challenge posed by a large number of excellent teams, the ASC Organizing Committee, and Shanghai University have decided to accommodate 25 teams for the ASC24 Finals, setting a new record for the highest number of teams qualified for onsite finals since the inception of the ASC competition in 2012.

Among the finalists, Huazhong University of Science and Technology's team demonstrated an in-depth grasp of supercomputing knowledge and technologies. Through precise performance bottleneck analysis and innovative optimization methods, they achieved outstanding results. Their exceptional performance across all tasks secured them the top rank in the preliminary round.

The ASC24 finals feature a lineup of traditional powerhouses, including Peking University - the champion of the 10th ASC onsite finals; the Chinese University of Hong Kong - the champion of the 10th ASC virtual finals; University of Science and Technology of China; Shanghai Jiao Tong University; and Friedrich-Alexander-University Erlangen-Nuremberg. Additionally, there is great excitement surrounding the debut of teams from National University of Cordoba, Macau University of Science and Technology, and Southwest Petroleum University, marking their first appearance in the ASC finals this year.

The ASC24 preliminaries included two computational tasks: Large Language Model (LLM) Inference Optimization and Seepage Numerical Simulation. Numerous participating teams excelled, showcasing remarkable capabilities in exploring and innovating in supercomputing application analysis, performance optimization, and parallel strategy design.

In the Large Language Model (LLM) Inference Optimization Challenge, participating teams were assigned the task of building and refining inference engines using the widely used open-source LLM, LLaMA2. The main goal was to achieve high-throughput inference on sample datasets provided by the organizing committee. Teams contending for success were expected to showcase a thorough understanding and proficiency in common parallel methods applicable to LLMs. Furthermore, they were tasked with implementing various techniques to enhance the inference process.

The team from Huazhong University of Science and Technology developed an LLM inference engine that incorporated tensor parallelism, KVCache, and PagedAttention. Additionally, they implemented asynchronous pipelining in parallel to address the issue of incomplete loading of model parameters on a single server. Moreover, they deployed a distributed memory manager on each node to ensure load balancing and conducted numerous comparative experiments to identify the optimal optimization method. These efforts propelled them to achieve the highest score. On the other hand, the team from Friedrich-Alexander-University Erlangen-Nuremberg utilized a customized TensorRT-LLM engine for their cluster. Through various experiments, they determined that a batch size of 8 resulted in twice the throughput compared to a batch size of 1. By leveraging tensor parallelism and batched generation, they achieved good performance.

The Seepage Simulation Task in ASC24 was designed to delve into the intricate flow patterns and characteristics of multiphase fluids within porous media using the open-source software OpenCAEPoro. Participating teams were tasked with simulating the seepage of multiphase fluids, including oil, gas, and water, specifically in scenarios related to petroleum extraction, based on the dataset provided by the organizing committee. The challenge required teams to skillfully optimize large-scale parallel computing processes, with a focus on improving the computing performance and parallel efficiency of discrete algorithms.

The team from Qinghai University utilized common optimization methods, including function inlining, loop expansion, and operator fusion, after conducting a detailed analysis of the seepage simulation software OpenCAEPoro. They also implemented vectorization and memory access optimization to address computational bottleneck matrix assembly, resulting in highly effective optimization. Meanwhile, the National Tsing Hua University team conducted a comprehensive analysis of OpenCAEPoro, pinpointing the primary bottleneck for CPU parallelization. They leveraged optimized compiler flags and computing libraries to achieve the best performance.

About ASC

The ASC Student Supercomputer Challenge is the world's largest student supercomputer competition, sponsored and organized by the Asia Supercomputer Community with support from experts and institutions across Asia, Europe, and America. The main objectives of ASC are to encourage the exchange and training of young supercomputing talent from different countries, improve supercomputing applications and R&D capacity, boost the development of supercomputing, and promote technical and industrial innovation. The first ASC Student Supercomputer Challenge was held in 2012 and has since attracted over 10,000 undergraduates from all over the world. Learn more for ASC at http://www.asc-events.net/StudentChallenge/index.html.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240207108190/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye